What Pharma Is Buying From AI Drug Discovery: Inside AstraZeneca’s insitro Deal
Dr. Dereck Mush, MD, MBA
VeriSIM Life
Predicts clinical success of drug candidates using biosimulation and machine learning.
What they do
VeriSIM Life offers BIOUST, an artificial intelligence driven biosimulation platform. Pharmaceutical and biotech researchers use the platform to predict how drug candidates will perform in animals and humans, reducing reliance on physical testing and preventing clinical trial failures.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Translational prediction
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- San Francisco, United States
- Region
- North America
- Founded
- 2017
- Total funding
- $25M raised
Notable investors: Morpheus Ventures, RRE Ventures, Intel Capital, Siri Ventures.
Also in Pharma & Drug Discovery
Related on The Signal
Dr. Dereck Mush, MD, MBA
The Great Directory Rollup: How H1 Is Building the Single Source of Truth for Provider Networks
Dr. Dereck Mush, MD, MBA
Beyond Gluten Avoidance: How argenx's CD122 Blockade Advances Pharmacological Protection in Celiac Disease
Dr. Dereck Mush, MD, MBA
The $2.4B Oral Macrocycle and Bispecific Surge: Why Big Pharma Is Buying Platform Engines Over Single Assets
Dr. Dereck Mush, MD, MBA